In an in-depth Q&A feature for Discover Pharma, Max van Heeswijk examines how pharmaceutical serialisation has transformed from a regulatory obligation into a competitive advantage.

Key insights include:

✅ Supply Chain Security: Serialisation enables real-time tracking of individual medicine packs, dramatically reducing counterfeiting risks and enabling precise, efficient recalls.

✅ Regulatory Evolution: Standards like the EU FMD and US DSCSA have driven global adoption of serialisation, pushing companies to harmonise data systems and improve interoperability across markets.

✅ Operational Benefits: Serialisation data enhances inventory control, supports targeted withdrawals, and strengthens pharmacovigilance by enabling precise traceability of adverse events.

✅ Technological Horizons: Emerging solutions like blockchain offer tamper-proof supply chain records, while AI promises predictive analytics for proactive issue resolution and smarter inventory management.

Max’s article highlights why serialisation is now a cornerstone of modern pharma supply chains—protecting patients, brands, and business continuity in an increasingly complex market.

📖 Read the full article here.

‍